Document Type : Research Paper


1 Department of Biology College of Science, University of Anbar, Anbar, Iraq;

2 Anbar University, College of Science, Department of Life Sciences


Acinetobacter baumannii is a biofilm-forming bacterium . In this study, 21 isolates of A. baumannii out of 120 different clinical sample were diagnosed with the Vitek 2 device, which isolated from wound , burn, urine tract infection sputum and well of the hospital. Antibiotic susceptibility test showed that all A. baumannii isolates were 100% fully resistant to piperacillin and rifampicin; 85.5% of the isolates showed resistance to trimethoprim , 80% resistant to amikacin , 76% were resistant to levofloxacin , gentamicin and ciprofloxacin. While resistant for tobramycin, meropenem and imipenem, were 66.66%, 47% and 33.33% respectively.
Result indicated that cultivated A. baumannii isolates in (T.S.B.) medium supplemented with 1% glucose enhanced the biofilm formation in 19 isolates stronger than cultivated with without glucose , when 3 isolates of A. baumannii formed power full ( strong ) and 5 forming moderate biofilm formation, while 11 isolate forming weak biofilm. As well es two out these 19 isolates where not formed the biofilm when cultivated in (T.S.B.) medium without glucose. Results of adding 5% glucose to (T.S.B.) medium showed that 19 isolates were formed biofilm , 10 out of 19 isolate formed moderate type of biofilm and (9) isolates formed weak type of biofilm. Whereas adding 8% of glucose to (T.S.B.) medium was inadequate for A. baumannii to form biofilm as 1% glucose . when 17 isolates formed biofilm, 3 out of 17 isolat isolates formed moderate biofilm, 14 formed biofilm weak biofilm formation and 4 isolate were negative for biofilm formation.


Main Subjects

[1] U. AL Hadeedy, N. Mahdi, and I. AL Jebory, “Isolation and Diagnosis of Acinetobacter Bumanniii Recently Isolated From Patients in Kirkuk Hospitals and Study their Antibiotics Resistance,” Kirkuk Univ. Journal-Scientific Stud., vol. 14, no. 3, pp. 155–173, Sep. 2019, doi: 10.32894/kujss.2019.14.3.12.
[2] L. C. S. Antunes, P. Visca, and K. J. Towner, “Acinetobacter baumannii: Evolution of a global pathogen,” Pathogens and Disease, vol. 71, no. 3. Blackwell Publishing Ltd, pp. 292–301, 2014. doi: 10.1111/2049-632X.12125.
[3] AL-Masaudi, “Acinetobacter spp. as nosocomial pathogens: epidemiology and resistance features,” 2016.
[4] P. K. Mulani MS, Kamble EE, Kumkar SN, Tawre MS, “"Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review,” 2019.
[5] S. Monem, B. Furmanek-Blaszk, A. Łupkowska, D. Kuczyńska-Wiśnik, K. Stojowska-Swędrzyńska, and E. Laskowska, “Mechanisms protecting acinetobacter baumannii against multiple stresses triggered by the host immune response, antibiotics, and outside host environment,” International Journal of Molecular Sciences, vol. 21, no. 15. MDPI AG, pp. 1–30, Aug. 01, 2020. doi: 10.3390/ijms21155498.
[6] et al. Luke NR , Sauberan SL, Russo TA, “Identification and character_ization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis identification and characteriza_tion of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide cor,” 2010.
[7] Z. Gedefie, A., Demsis, W., Ashagrie, M., Kassa, Y., Tesfaye, M., Tilahun, M., … Sahle, “Acinetobacter baumannii Biofilm Formation and Its Role in Disease Pathogenesis: A Revie,” 2021.
[8] Michael Otto, “Staphylococcal Infections: Mechanisms of Biofilm Maturation and Detachment as Critical Determinants of Pathogenicity,” 2013.
[9] R. Landini, P., Antoniani, D., Burgess, J. G., & Nijland, “Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal,” 2010.
[10] B. You, Y., Xue, T., Cao, L., Zhao, L., Sun, H., & Sun, “Staphylococcus aureus glucose-induced biofilm accessory proteins, GbaAB, influence biofilm formation in a PIA-dependent manner. International Journal of Medical Microbiology, 304(5–6), 603–612.,” 2014.
[11] L. Pan, Y., Breidt, F. Jr, & Gorski, “Synergistic effects of sodium chloride, glucose, and temperature on biofilm formation by Listeria monocytogenes serotype 1/2a and 4b strains. Applied and Environment Microbiology, 76(5), 1433–1441.,” 2010.
[12] N. K. Pour, D. H. Dusane, P. K. Dhakephalkar, F. R. Zamin, S. S. Zinjarde, and B. A. Chopade, “Biofilm formation by Acinetobacter baumanniistrains isolated from urinary tract infection and urinary catheters,” FEMS Immunol. Med. Microbiol., vol. 62, no. 3, pp. 328–338, Aug. 2011, doi: 10.1111/j.1574-695X.2011.00818.x.
[13] “Clinical and Laboratory Standards Institute (CLSI). 2022. Performance Standards for Antimicrobial Susceptibility Testing. 26th ed. Informational Supplement. M100S, Wayne.” 2022.
[14] M. Asif, I. A. Alvi, and S. Ur Rehman, “Insight into acinetobacter baumannii: Pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities,” Infection and Drug Resistance, vol. 11. Dove Medical Press Ltd., pp. 1249–1260, 2018. doi: 10.2147/IDR.S166750.
[15] M. F. Authman, S. H., Ali, F. S., & Al-Marjani, “Biofilm Formation in Imipenem-Resistant Acinetobacter baumannii from the Intensive Care Unit. Journal of Global Pharma Technology. 10(9):404-411.,” 2017.
[16] E. C. Eze, H. Y. Chenia, and M. E. El Zowalaty, “Acinetobacter baumannii biofilms: Effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments,” Infection and Drug Resistance, vol. 11. Dove Medical Press Ltd., pp. 2277–2299, 2018. doi: 10.2147/IDR.S169894.
[17] Y. W. Pengfei She, Yanle Wang, Yiqing Liu, Fang Tan, Lihua Chen, Zhen Luo, “Effects of exogenous glucose on Pseudomonas aeruginosa biofilm formation and antibiotic resistance,” 2019.